QR code

High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

Aim. Hodgkin’s lymphoma (HL) patients with primary refractory (PRef) course of disease or relapses refractory to the previous 2nd line therapy (RRel) often are not given high-dose chemotherapy with autologous stem cell support (ASCS), and this refuse is motivated by its poor efficacy and high toxici...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: N. V. Zhukov, A. G. Rumyantsev, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, M. A. Vernyuk, A. D. Kaprin
Formaat: Artigo
Taal:Russo
Gepubliceerd in: Practical Medicine Publishing House 2014-07-01
Reeks:Клиническая онкогематология
Onderwerpen:
hodgkin’s lymphoma
high-dose chemotherapy
autologous hematopoietic stem cells transplantation
primary resistance
resistant relapse
Online toegang:https://bloodjournal.ru/index.php/coh/article/view/616
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items